文献速递细菌感染、耐药与抗菌药物

临床来源耐甲氧西林金黄色葡萄球菌中新型苯丙醇-噁唑烷酮-四环素耐药基因poxtA的特征分析

Characterization of poxtA, a novel phenicol-oxazolidinone-tetracycline resistance gene from an MRSA of clinical origin.
PubMed 文献 · J Antimicrob Chemother · 2018-01-01

研究对一株临床来源、对利奈唑胺高度耐药且携带cfr基因的耐甲氧西林金黄色葡萄球菌(MRSA)进行全基因组分析,鉴定出新型耐药基因poxtA。该基因编码的蛋白与OptrA有32%一致性,属ABC-F家族,在三种宿主菌中表达均可降低对苯丙醇类、噁唑烷酮类和四环素类的敏感性,并位于含两个IS1216元件的复合转座子样结构中。

要点

  • poxtA编码ABC-F家族蛋白,与OptrA有32%一致性,介导核糖体保护。
  • 在埃希菌、金黄色葡萄球菌和粪肠球菌中表达poxtA均降低对苯丙醇类、噁唑烷酮类和四环素类的敏感性。
  • poxtA位于含两个IS1216元件的复合转座子样结构,可能参与水平传播。

核心结论

  • 在临床来源MRSA基因组中鉴定出新型耐药基因poxtA,编码抗生素耐药ABC-F家族蛋白。
  • PoxtA可赋予对苯丙醇类、噁唑烷酮类和四环素类的敏感性降低,并关联一个可能促成其水平传播的假定移动元件。

研究设计与样本

  • 对先前描述的一株对利奈唑胺高度耐药且携带cfr基因的MRSA菌株AOUC-0915进行全基因组测序生物信息学分析以鉴定poxtA。
  • 将poxtA克隆入穿梭质粒载体并在大肠埃希菌、金黄色葡萄球菌和粪肠球菌中表达以研究蛋白功能。
  • 采用标准方法进行蛋白和基因水平的比较序列分析。

主要发现

  • poxtA编码蛋白与OptrA有32%一致性,具有ATP结合盒(ABC)蛋白超家族F谱系的结构特征,该谱系通过核糖体保护导致抗生素耐药。
  • poxtA在大肠埃希菌、金黄色葡萄球菌和粪肠球菌中表达均能降低对苯丙醇类、噁唑烷酮类和四环素类的敏感性。
  • 数据库检索在粪肠球菌、屎肠球菌和乳酸片球菌菌株(多为动物来源)中检出poxtA,并在某些梭菌目基因组中发现poxtA同源物。
  • 遗传背景分析显示poxtA位于包含两个IS1216元件的复合转座子样结构中。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To characterize a novel phenicol-oxazolidinone-tetracycline resistance gene, named poxtA, identified in a previously described MRSA strain that was highly resistant to linezolid and also carried the cfr gene. METHODS: The poxtA gene was identified by bioinformatic analysis of the whole genome sequence of Staphylococcus aureus AOUC-0915. The poxtA gene was cloned in a shuttle plasmid vector and expressed in Escherichia coli, S. aureus and Enterococcus faecalis to investigate the protein function. Comparative sequence analyses at the protein and genetic levels were carried out using standard procedures. RESULTS: The poxtA gene encodes a protein that is 32% identical to OptrA and exhibits structural features typical of the F lineage of the ATP-binding cassette (ABC) protein superfamily that cause antibiotic resistance by ribosomal protection. Expression of poxtA in E. coli, S. aureus and E. faecalis was able to decrease susceptibility to phenicols, oxazolidinones and tetracyclines. A database search identified the presence of poxtA in E. faecalis, Enterococcus faecium and Pediococcus acidilactici strains, mostly of animal origin, and revealed the presence of poxtA homologues in the genomes of some Clostridiales. Analysis of the genetic context revealed that poxtA was located in a composite transposon-like structure containing two IS1216 elements. CONCLUSIONS: A novel resistance gene, named poxtA, encoding a protein of the antibiotic resistance (ARE) ABC-F lineage, was identified in the genome of an MRSA of clinical origin. PoxtA can confer decreased susceptibility to phenicols, oxazolidinones and tetracyclines and is associated with a putative mobile element that could contribute to its horizontal dissemination.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Antonelli A, D'Andrea MM, Brenciani A, et al. Characterization of poxtA, a novel phenicol-oxazolidinone-tetracycline resistance gene from an MRSA of clinical origin. J Antimicrob Chemother. 2018. PMID: 29635422. doi:10.1093/jac/dky088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。